Articles in section Mergers & Acquisitions

<< Licensing

642 articles

Opinion & Analysis >>

<< Previous

Pages 1 2 3 4 5 .. 65

Next >>

Adaptimmune and TCR2 Merge to Form a Solid Tumour Company Published: 28 Mar-2023
By: Shweta Gupta & Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 3
Sanofi Buys Provention Bio and its Type 1 Diabetes Drug for US$2.9 B Published: 24 Mar-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 3
Pfizer to Acquire ADC Cancer Specialist Seagen for US$43 B Published: 15 Mar-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 3
Ono Pharmaceutical Acquires Multiple Research-Stage Oncology Programmes from KSQ Therapeutics Published: 4 Feb-2023
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2023 Issue: 2
Sun Pharma Acquires Concert Pharmaceuticals to Broaden its Dermatology Portfolio Published: 1 Feb-2023
By: Ayush Saxena
Abstract Fulltext:
Volume: 2023 Issue: 2
Amgen to Acquire Horizon Therapeutics for US$28.3 B Published: 19 Dec-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 12
AstraZeneca Bolsters Pipeline with Neogene Therapeutics and C4X Discovery Deals Published: 9 Dec-2022
By: Lucy Haggerty & Amit Kaushik
Abstract Fulltext:
Volume: 2022 Issue: 12
Merck & Co. Acquires Imago BioSciences for US$1.35 B Published: 26 Nov-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 11
J&J to Acquire Abiomed for US$16.6 B Published: 11 Nov-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 11
Incyte to Acquire Villaris Therapeutics for US$1.43 B Published: 26 Oct-2022
By: Amit Kaushik
Abstract Fulltext:
Volume: 2022 Issue: 10

Login

Username:

Password:

Keep me logged in